Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

733.51 +8.64 (+1.19%)
Official Closing Price Updated: 7:00 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,009,365
Open 723.48
Bid (Size) 733.17 (3)
Ask (Size) 734.99 (1)
Prev. Close 724.87
Today's Range 721.00 - 737.45
52wk Range 392.25 - 800.78
Shares Outstanding N/A
Dividend Yield 0.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Forget Nvidia, These Unstoppable Stocks Are Better Buys
These stocks have tremendous potential, and it doesn't depend on the growth prospects for artificial intelligence. 
Via The Motley Fool
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On
Eli Lilly may be on the verge of another breakthrough, thanks to its hit GLP-1 medications. 
Via The Motley Fool

Performance

YTD
+23.86%
+23.86%
1 Month
-5.71%
-5.71%
3 Month
+13.72%
+13.72%
6 Month
+29.66%
+29.66%
1 Year
+85.30%
+85.30%

More News

Read More
3 Dividend Stocks to Buy and Hold for the Next Decade
Via The Motley Fool
SPDR ETF Report For Friday, April 26
Via Talk Markets
Topics ETFs
Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
Via Benzinga
Topics Economy
Exposures Economy Interest Rates
Market Whales and Their Recent Bets on LLY Options
Via Benzinga
ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes
Via Investor's Business Daily
Dividend Legends: 3 Stocks With Over 100 Years of Payouts
Via InvestorPlace
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Via Investor's Business Daily
Don’t Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List
Via InvestorPlace
Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
Via Benzinga
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
Via The Motley Fool
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
Via InvestorPlace
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Via The Motley Fool
REITs Q1 Earnings Begin On Solid Note
Via Benzinga
Better Buy: Pfizer vs. Viking Therapeutics
Via The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
Via InvestorPlace
Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma
Via Benzinga
7 High-Flying Stocks That Are Majorly Overdue for a Pullback
Via InvestorPlace
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
Via Benzinga
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Via MarketBeat
6 Stocks Positioned to Soar as Investors Focus on MASH
Via TheNewswire.com
Capturing Consumer Spending on Health Care with XLV
Via News Direct
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.